Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FOLD | AMGN | GILD | VRTX | BIIB |
| Company | Amicus Therapeutics | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 11.16 | 333.93 | 83.37 | 483.78 | 198.13 |
| High | 11.26 | 339.00 | 84.52 | 483.78 | 199.78 |
| Low | 10.90 | 331.00 | 82.76 | 474.25 | 196.81 |
| Last | 10.91 | 333.58 | 83.90 | 475.13 | 197.58 |
| Change | -0.29 | +0.78 | +0.85 | -6.13 | -0.63 |
| % Change | -2.59% | +0.23% | +1.02% | -1.27% | -0.32% |
| Volume | 2,173,019 | 923,573 | 6,843,158 | 574,451 | 448,717 |
| 20-Day Average Volume | 1,817,690 | 1,709,301 | 6,297,032 | 962,774 | 789,486 |
| Previous Close | 11.20 | 332.80 | 83.05 | 481.26 | 198.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.45 | 329.29 | 79.64 | 480.38 | 201.85 |
| 20-Day Raw Stochastic | 3.20% | 75.16% | 90.58% | 39.22% | 35.98% |
| 20-Day Relative Strength | 47.26% | 56.03% | 71.94% | 48.33% | 39.72% |
| Weighted Alpha | -8.40 | +26.01 | +18.32 | +32.88 | -23.58 |
| Today's Opinion | 16% Buy | 88% Buy | 88% Buy | 40% Buy | 100% Sell |
| Previous Opinion | 24% Buy | 88% Buy | 88% Buy | 56% Buy | 100% Sell |
| Last Month's Opinion | 32% Buy | 72% Buy | 40% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.57% since 09/11/24 | +1.18% since 09/11/24 | +3.71% since 09/11/24 | +0.31% since 09/11/24 | -0.66% since 09/11/24 |
| Low | 10.94 on 09/18/24 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 468.46 on 09/12/24 | 192.25 on 09/13/24 |
| High | 11.42 on 09/13/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 490.15 on 09/16/24 | 202.79 on 09/17/24 |
| 1-Month | |||||
| %Chg | -4.27% since 08/16/24 | +3.87% since 08/16/24 | +13.77% since 08/16/24 | -0.24% since 08/16/24 | -2.05% since 08/16/24 |
| Low | 10.94 on 09/18/24 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 12.19 on 08/21/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +12.38% since 06/18/24 | +9.12% since 06/18/24 | +32.92% since 06/18/24 | +1.91% since 06/18/24 | -11.57% since 06/18/24 |
| Low | 9.35 on 08/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 12.19 on 08/21/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -5.18% since 03/18/24 | +23.25% since 03/18/24 | +14.58% since 03/18/24 | +15.76% since 03/18/24 | -9.86% since 03/18/24 |
| Low | 9.02 on 05/13/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 12.24 on 03/21/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,317,429 | 178,525,568 | 103,468,096 | 124,190,592 | 28,858,782 |
| Shares Outstanding, K | 296,199 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 399,360,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -151,580,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 126,670,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | -15,700,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 0.69 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.06 on 08/08/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 08/08/24 | 10/29/24 | 11/05/24 | 11/04/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.02 | 17.69 | 0.00 | 12.27 |